Outcomes due to CSVT
No mortality secondary to CSVT was observed in our study. Neuroimaging
(CT and MR venography) was used for follow-up. After 3 months, the
majority of patients had complete radiological resolution following
anticoagulation (LMWH). Some patients continued to receive LMWH, if
there were more scheduled Asp doses to receive. No recurrent CSVT was
observed. Only one patient whose anticoagulation was not started
immediately upon diagnosis because of a large concomitant bleed, ended
up with a minor neurologic deficit.